Reaction

Viith Nerve Paralysis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,453 reports · 52 co-occurring drugs

As of the last recalculation, Viith Nerve Paralysis appears in 3,453 FAERS reports alongside 52 co-occurring drug terms. The strongest observed disproportionality signal is DROSPIRENONE AND ETHINYL ESTRADIOL (PRR 11.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Drospirenone And Ethinyl Estradiol	80	11.1	11.2
Peginterferon Alfa-2A	76	8.6	8.7
Onabotulinumtoxina	102	8.2	8.2
Fondaparinux Sodium	10	7.5	7.5
Amlodipine Besylate And Valsartan	12	6.6	6.6
Botulinum Toxin Type A	13	6.3	6.3
Terazosin Hydrochloride	9	6.1	6.1
Ribavirin	62	5.9	5.9
Sevoflurane	8	5.8	5.8
Valsartan And Hydrochlorothiazide	13	5.8	5.8
Desloratadine	10	5.6	5.6
Efavirenz	10	5.4	5.4
Meclizine Hcl 12.5Mg	12	5.3	5.3
Meclizine Hcl 25Mg	12	5.3	5.3
Meclizine Hcl 12.5 Mg	12	5.3	5.3
Meclizine Hcl 25 Mg	12	5.3	5.3
Mercaptopurine	15	5.2	5.2
Nilotinib	22	4.5	4.5
Interferon Beta-1A	132	4.2	4.2
Vemurafenib	8	4.0	4.0
Ranibizumab	17	3.9	3.9
Ziprasidone Mesylate	9	3.8	3.8
Phenytoin	13	3.8	3.8
Alteplase	9	3.6	3.6
Metformin Hcl	32	3.5	3.5
Cytarabine	34	3.4	3.4
Dabigatran Etexilate Mesylate	41	3.4	3.4
Ziprasidone	10	3.4	3.4
Sitagliptin And Metformin Hydrochloride	12	3.4	3.4
Dabigatran Etexilate	42	3.3	3.3
Etonogestrel And Ethinyl Estradiol	12	3.3	3.3
Erlotinib	5	3.1	3.1
Natalizumab	92	3.1	3.1
Sorafenib	10	2.9	2.9
Ipilimumab	20	2.8	2.8
Asenapine Maleate	4	2.8	2.8
Sofosbuvir	9	2.8	2.8
Agalsidase Beta	4	2.6	2.6
Fingolimod Hcl	37	2.6	2.6
Varenicline Tartrate	34	2.6	2.6
Erlotinib Hydrochloride	5	2.4	2.4
Ledipasvir And Sofosbuvir	7	2.2	2.2
Teriflunomide	16	2.1	2.1
Paricalcitol	5	2.1	2.1
Somatropin	24	2.0	2.0
Aflibercept	10	1.9	1.9
Dimethyl Fumarate	37	1.8	1.8
Glatiramer Acetate	18	1.8	1.8
Isotretinoin	13	1.6	1.6
Glycerin, Lidocaine	3	1.3	1.3
Docosanol	3	1.2	1.2
Paliperidone Palmitate	6	1.1	1.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.